Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
(41/50)
(+info)
Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways.
(42/50)
(+info)
A3 adenosine receptor inhibition improves the efficacy of hypertonic saline resuscitation.
(43/50)
(+info)
Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.
(44/50)
(+info)
Xanthines as adenosine receptor antagonists.
(45/50)
(+info)
Disparity in FcepsilonRI-induced degranulation of primary human lung and skin mast cells exposed to adenosine.
(46/50)
(+info)
Investigational A(3) adenosine receptor targeting agents.
(47/50)
(+info)
Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor.
(48/50)
(+info)